Specialized Formulations of SN-38 for High-Security and Extreme Environments

Publication ID: 24-11857630_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Formulations of SN-38 for High-Security and Extreme Environments,” Published Technical Disclosure No. 24-11857630_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857630_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,630.

Summary of the Inventive Concept

This inventive concept adapts the original formulation of SN-38 with poly(amino acid) block polymers for specific, high-stakes applications, such as high-security medical storage, disaster relief, and extreme weather conditions.

Background and Problem Solved

The original patent disclosed formulations of SN-38 with poly(amino acid) block polymers for general chemotherapy. However, these formulations lacked the necessary adaptations for use in high-security, disaster relief, or extreme weather conditions. The new inventive concept addresses these limitations by incorporating specialized features and components to ensure the formulations remain effective and secure in these unique environments.

Detailed Description of the Inventive Concept

The new inventive concept comprises formulations of SN-38 with poly(amino acid) block polymers, tailored to meet the specific demands of high-security medical storage, disaster relief, and extreme weather conditions. For high-security medical storage, the formulation is stored in a tamper-evident container. For disaster relief, the composition is stored in a portable, waterproof container and administered to patients in need. For extreme weather conditions, the pharmaceutical kit includes a thermally-insulated container and a cryoprotectant. Additionally, the composition is adapted to withstand low atmospheric pressure for high-altitude medical treatment and compact, shock-resistant containers for emergency medical response.

Novelty and Inventive Step

The new inventive concept's novelty lies in the adaptation of the original formulation for specific, high-stakes applications, incorporating specialized features and components to ensure the formulations remain effective and secure in these unique environments. The inventive step is the recognition of the need for these adaptations and the development of tailored solutions to address these needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different poly(amino acid) block polymers, varying the ratio of SN-38 to polymer, or incorporating additional components to enhance stability or efficacy. Variations could also include the development of formulations for other high-stakes applications, such as space exploration or military operations.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of high-security medical storage, disaster relief, and extreme weather conditions. Target industries include government agencies, humanitarian organizations, and pharmaceutical companies specializing in niche markets.

CPC Classifications

SectionClassGroup
A A61 A61K47/34
A A61 A61K9/08
A A61 A61K9/19
A A61 A61K31/4375
A A61 A61K31/513
A A61 A61K31/519
A A61 A61K45/06
A A61 A61K47/26

Original Patent Information

Patent NumberUS 11,857,630
TitleFormulations of SN-38 with poly(amino acid) block polymers
Assignee(s)TYNDALL FORMULATION SERVICES, LLC